VP Clinical and Regulatory Development CBC
Ceva
Philadelphia, Pennsylvania, United States
Dr. Traas is currently the VP of clinical and regulatory development for Ceva Biotechnology Campus, formerly Scout Bio which she joined in 2019. Her current research includes gene therapies and protein therapeutics (including monoclonal antibodies) for pets. She has over 20 years of experience as a clinical research leader and veterinarian, including over a decade at Boehringer Ingelheim (BI) Animal Health. Dr. Anne Traas earned her DVM from the University of Minnesota. She completed her residency in medical genetics and a masters in translational research at the University of Pennsylvania. She is board certified in theriogenology.
Disclosure information not submitted.
Industry Session Lunch: AAV Vectored Therapeutics: Gene Therapy in Animal Health
Thursday, June 19, 2025
12:15 PM – 1:45 PM ET